|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.430 CNY | -1.34% |
|
+2.07% | -19.89% |
| 05-25 | North China Pharma Gets China Nod for Kidney Anemia Drug | MT |
| 04-24 | North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 7.6B 1.12B 969M 892M 838M 1.57B 106B 1.59B 10.54B 4.11B 52.06B 4.22B 4.13B 180B | P/E Ratio 2024 |
69.9x | P/E Ratio 2025 | 51.7x |
|---|---|---|---|---|---|
| Enterprise Value | 17.27B 2.56B 2.2B 2.03B 1.9B 3.57B 242B 3.61B 23.96B 9.34B 118B 9.59B 9.39B 410B | EV / Sales 2024 |
1.89x | EV / Sales 2025 | 2.07x |
| Free-Float |
40.02% | Yield 2024 |
0.58% | Yield 2025 | 0.63% |
| 1 day | -1.34% | ||
| 1 week | +2.07% | ||
| Current month | -2.42% | ||
| 1 month | -12.28% | ||
| 3 months | -21.87% | ||
| 6 months | -19.89% | ||
| Current year | -19.89% |
| 1 week | 4.32 |  | 4.55 |
| 1 month | 4.3 | | 5.04 |
| Current year | 4.3 | | 6.07 |
| 1 year | 4.3 | | 7.46 |
| 3 years | 3.83 | | 7.46 |
| 5 years | 3.83 | | 13.45 |
| 10 years | 3.83 | | 20.24 |
| Manager | Title | Age | Since |
|---|---|---|---|
Min Zhang
CEO | Chief Executive Officer | 55 | 28/11/2025 |
Zhi Guang Xiao
DFI | Director of Finance/CFO | 46 | 10/04/2024 |
Jing Yang
IRC | Investor Relations Contact | 45 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Yao Cao
CHM | Chairman | 49 | 22/03/2016 |
Li Xin Wang
CHM | Chairman | 54 | 10/04/2023 |
Ji Gang Xie
BRD | Director/Board Member | 53 | 23/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25/02/25 | Buy | Chairman | 1,600 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.34% | +2.07% | -27.02% | -21.59% | 1.12B | |
| -0.61% | -1.94% | +39.00% | +150.72% | 1,001B | |
| -0.20% | -0.77% | +51.51% | +43.20% | 566B | |
| +0.40% | -1.31% | +16.56% | +60.47% | 393B | |
| +0.17% | +2.29% | +24.04% | +16.53% | 326B | |
| +0.18% | +0.55% | +25.25% | +31.76% | 276B | |
| +0.41% | -0.91% | +25.14% | +14.56% | 277B | |
| +1.88% | +1.34% | -41.21% | -47.01% | 193B | |
| -0.77% | +0.95% | +17.69% | +51.46% | 188B | |
| +2.36% | +1.38% | +14.80% | +61.34% | 158B | |
| Average | +0.50% | +0.41% | +14.58% | +36.14% | 337.79B | |
| Weighted average by Cap. | +0.56% | -0.41% | +27.87% | +67.36% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 9.87B 1.46B 1.26B 1.16B 1.09B 2.04B 138B 2.06B 13.69B 5.33B 67.6B 5.48B 5.36B 234B | 9.24B 1.37B 1.18B 1.08B 1.02B 1.91B 129B 1.93B 12.82B 4.99B 63.3B 5.13B 5.02B 219B |
| Net income | 127M 18.79M 16.19M 14.91M 14M 26.28M 1.78B 26.56M 176M 68.63M 870M 70.5M 69M 3.01B | 183M 27.08M 23.34M 21.49M 20.18M 37.88M 2.56B 38.28M 254M 98.93M 1.25B 102M 99.47M 4.34B |
| Net Debt | 9.79B 1.45B 1.25B 1.15B 1.08B 2.03B 137B 2.05B 13.58B 5.29B 67.05B 5.43B 5.32B 232B | 9.67B 1.43B 1.23B 1.14B 1.07B 2B 135B 2.02B 13.42B 5.23B 66.26B 5.37B 5.26B 230B |
Employees
9,972
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/06/26 | 4.430 ¥ | -1.34% | 9,762,000 |
| 15/06/26 | 4.490 ¥ | +0.22% | 13,249,510 |
| 12/06/26 | 4.480 ¥ | +2.99% | 14,514,800 |
| 11/06/26 | 4.350 ¥ | -0.91% | 11,911,500 |
| 10/06/26 | 4.390 ¥ | +1.15% | 11,704,400 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600812 Stock
Select your edition
All financial news and data tailored to specific country editions
